Norepinephrine, also known as noradrenaline or Levophed, is an endogenous catecholamine hormone and neurotransmitter produced primarily in the adrenal medulla and the postganglionic neurons of the sympathetic nervous system. It belongs to the chemical class of catecholamines, which are derived from the amino acid tyrosine. Norepinephrine plays a crucial role in the body's fight-or-flight response, influencing heart rate, blood pressure, and blood glucose levels. Researchers have extensively studied its role in cardiovascular regulation, mood disorders, and stress response. It is also a focus of research in neurodegenerative diseases and psychiatric conditions such as depression and anxiety. Norepinephrine exerts its effects by binding to adrenergic receptors, primarily the alpha-1, alpha-2, and beta-1 receptors. This binding initiates a cascade of intracellular events, including the activation of second messenger systems such as cyclic AMP, leading to physiological responses like vasoconstriction and increased cardiac output. The pharmacokinetic properties of norepinephrine include a short circulating half-life of approximately 2-3 minutes when administered intravenously, as it is rapidly metabolized by monoamine oxidase and catechol-O-methyltransferase. Its bioavailability is poor when administered orally due to extensive first-pass metabolism. Clinically, norepinephrine is used as a vasopressor in acute hypotensive states such as septic shock. It is approved by regulatory agencies like the FDA for intravenous use in critical care settings. Researchers have observed its efficacy in restoring blood pressure and improving perfusion in critically ill patients.